UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Myasthenia Gravis
Clinical trial NCT06933563 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06933563
- Sponsor
- Zhejiang University
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-01
- Primary completion
- 2026-04-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.